ECONOMIC DEPENDENCY: (Details) (USD $)	12 Months Ended			12 Months Ended			12 Months Ended
	Sep. 30, 2008	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2008 U.S. Government	Sep. 30, 2012 U.S. Government	Sep. 30, 2011 U.S. Government	Sep. 30, 2011 DVA Pharmaceutical and other medical services Maximum	Sep. 30, 2011 DVA Pharmaceutical services	Sep. 30, 2011 DVA Pharmaceutical services Maximum	Sep. 30, 2011 DVA Other medical services	Sep. 30, 2011 DVA Other medical services Maximum	Sep. 30, 2012 Service or contract concentration Healthcare services	Sep. 30, 2011 Service or contract concentration Healthcare services	Sep. 30, 2012 Service or contract concentration DVA	Sep. 30, 2012 Revenue concentration Customer concentration U.S. Government	Sep. 30, 2011 Revenue concentration Customer concentration U.S. Government	Sep. 30, 2012 Revenue concentration Customer concentration DVA	Sep. 30, 2011 Revenue concentration Customer concentration DVA
ECONOMIC DEPENDENCY
Concentration risk percentage												54.00%	45.00%		100.00%	100.00%	95.00%	94.00%
Value of award							$ 145,000,000		$ 145,000,000		$ 10,000,000
Term of award							5 years		5 years	5 years
Percentage of revenue generated from Blanket Purchase Agreement								45.00%
Percentage of revenue generated from other government contracts														50.00%
Accounts receivable		13,028,000	11,112,000		13,000,000	11,100,000
Unbilled accounts receivable					9,300,000	10,500,000
Contract revenue, nonrecurring	10,800,000			10,800,000
Unbilled accounts receivable relating to retroactive adjustments from 2008					$ 10,800,000	$ 9,300,000